Abstract:The clinical efficacy of tyrosine kinase inhibitors supports the dependence of distinct subsets of cancers on specific driver mutations for survival, a phenomenon called "oncogene addiction." We demonstrate that PUMA and BIM are the key apoptotic effectors of tyrosine kinase inhibitors in breast cancers with amplification of the gene encoding human epidermal growth factor receptor 2 (HER2) and lung cancers with epidermal growth factor receptor (EGFR) mutants. The BH3 domain containing proteins BIM and PUMA can directly activate the proapoptotic proteins BAX and BAK to permeabilize mitochondria, leading to caspase activation and apoptosis. We delineated the signal transduction pathways leading to the induction of BIM and PUMA by tyrosine kinase inhibitors. Inhibition of the mitogen-activated or extracellular signal-regulated protein kinase kinase (MEK)-extracellular signal-regulated kinase (ERK) pathway caused increased abundance of BIM, whereas antagonizing the phosphoinositide 3-kinase (PI3K)-AKT pathway triggered nuclear translocation of the FOXO transcription factors, which directly activated the PUMA promoter. In a mouse breast tumor model, the abundance of PUMA and BIM was increased after inactivation of HER2. Moreover, deficiency of Bim or Puma impaired caspase activation and reduced tumor regression caused by inactivation of HER2. Similarly, deficiency of Puma impeded the regression of EGFR(L858R)-driven mouse lung tumors upon inactivation of the EGFR-activating mutant. Overall, our study identified PUMA and BIM as the sentinels that interconnect kinase signaling networks and the mitochondrion-dependent apoptotic program, which offers therapeutic insights for designing novel cell death mechanism-based anticancer strategies.

PUMA is directly activated by NF-kappaB and contributes to TNF-alpha-induced apoptosis.

PUMA is directly activated by NF- κ B and contributes to TNF- α -induced apoptosis

PUMA, a Novel Proapoptotic Gene, Is Induced by p53

PUMA, a potent killer with or without p53

PUMA amplifies necroptosis signaling by activating cytosolic DNA sensors

PUMA Induces the Rapid Apoptosis of Colorectal Cancer Cells

The Nuclear Function of P53 is Required for Puma-Mediated Apoptosis Induced by Dna Damage

Puma Promotes Bax Translocation by Both Directly Interacting with Bax and by Competitive Binding to Bcl-X-L During Uv-Induced Apoptosis

Stabilization of P53 is a Novel Mechanism for Proapoptotic Function of NF-κB

P85 Alpha Acts As A Novel Signal Transducer For Mediation Of Cellular Apoptotic Response To Uv Radiation

FOXO3a-dependent regulation of Puma in response to cytokine/growth factor withdrawal.

Tumor Protein p63/Nuclear Factor κB Feedback Loop in Regulation of Cell Death

JNK1-dependent PUMA Expression Contributes to Hepatocyte Lipoapoptosis

Puma Overexpression Induces Reactive Oxygen Species Generation And Proteasome-Mediated Stathmin Degradation In Colorectal Cancer Cells

Pro-apoptotic Function of PUMA in Human Tumor

Puma Promotes Bax Activation in A Foxo3a-Dependent Manner in Sts-Induced Apoptosis

Regulation of PUMA- α by p53 in cisplatin-induced renal cell apoptosis

The BH3-only Protein, PUMA, is Involved in Oxaliplatin-Induced Apoptosis in Colon Cancer Cells

PUMA and BIM Are Required for Oncogene Inactivation–Induced Apoptosis

ERK and JNK mediate TNFalpha-induced p53 activation in apoptotic and autophagic L929 cell death.

Regulation of Bax activation and apoptotic response to UV irradiation by p53 transcription-dependent and -independent pathways.